ÖÐÐÄ̼´úл(Central Carbon Metabolism, CCM)¹Å°åÒâÒåÉÏ°üÀ¨Ìǽͽâ;¾¶(Embden-Meyerhof-Parnas pathway, EMP)¡¢Á×ËáÎìÌÇ;¾¶(Pentose Phosphate Pathway, PPP)ÒÔ¼°ÈýôÈËáÑ»·Í¾¾¶(Tricarboxylic Acid Cycle, TCA)¡£ÖÐÐÄ̼´úлÊÇÉúÎïÌåËùÐèÄÜÁ¿µÄÖ÷ҪȪԴ£¬²¢ÎªÌåÄÚÆäËû´úлÌṩǰÌåÎïÖÊ£¬ÇÒCCMÖÐÒªº¦Ã¸µÄø»î¼°ÂÑ°×±í´ïˮƽ¾ßÓÐÒÅ´«Çø·ÖÐÔ£¬ÀàËÆÓÚ±íÐÍ£¬¿ÉÓÃÓÚ´óÖµÄÖÖÊôÇø·Ö¡£¼øÓÚCCMÔÚËùÓÐÉúÃüÌåÖеÄÖ÷Òª×÷Óã¬Ñо¿Æä´úлÎïµÄ±í´ï¾ßÓкÜÊÇÖ÷ÒªµÄÒâÒ塣ͨ¹ýÀë×ÓÉ«Æ×ÖÊÆ×ÁªÓÿÉÒÔ¸ßͨÁ¿¼ì²âÑù±¾ÖÐÐÄ̼´úлͨ·Öи÷ÎïÖʵĺ¬Á¿£¬Í¨¹ýÊý¾ÝÆÊÎöÒÔÈ·¶¨ÎïÖʼäµÄת±ä¹Øϵ¡£
TCAÑ»·µÄÖÐÐIJúÆ·¿ÉÓÃ×÷Ö²ÎïÉú³¤ºÍ·¢ÓýËùÐèµÄ°±»ùËᣬºËËáºÍϸ°û±ÚÒòËصÄÉúÎïºÏ³Éµ×Îµ±CCMÒ쳣ʱ£¬»á¶ÔÖ²ÎïµÄÉú³¤·¢ÓýÔì³ÉÓ°Ï죬ÔÚÐóÄÁÒµÉÏ£¬CCMÒì³£³ýÁË»áÓ°Ï춯ÎïµÄÉú³¤·¢Óý¡¢»¹»á¶Ô¶¯ÎïÆ·ÖÊÔì³ÉÓ°Ïì¡£¼øÓÚCCMÔÚËùÓÐÉúÃüÌåÖеÄÖ÷Òª×÷Óã¬Ñо¿Æä´úлÎïµÄ±í´ï¾ßÓкÜÊÇÖ÷ÒªµÄÒâÒå¡£
ÖÐÐÄ̼´úл¼ì²âÁбí
×¢£º¹²¿É¼ì²â56ÖÖÖÐÐÄ̼´úлÎïÖÊ
¶¨ÐÔ¶¨Á¿×¼£¬¹¹½¨ÎïÖʱê×¼ÇúÏߣ¬ÌṩÎïÖʵľø¶Ôº¬Á¿
ÊÖÒÕ³ÉÊìÎȹ̡¢Çø·ÖÂʸߡ¢Ñ¡ÔñÐÔºÃ
Ñù±¾Ç°´¦Öóͷ£ÂÄÀú¸»ºñ
רҵµÄÊý¾ÝÆÊÎöÍŶÓ
? Ñù±¾ÒªÇó
Ö²Îï×éÖ¯£º200 mg/sample
¶¯Îï¼°ÁÙ´²×éÖ¯Ñù±¾£º200 mg/sample
ѪÇ塢Ѫ½¬£º200 ¦ÌL/sample
ÄòÒº£º200 ¦ÌL/sample
ϸ°û¡¢Î¢ÉúÎ1X107 cells/sample
? ÉúÎïѧÖظ´
Ñù±¾ÊýÄ¿£º Ö²ÎïºÍ΢ÉúÎïn¡Ý6£¬¶¯ÎïÑù±¾n¡Ý10£¬ÁÙ´²Ñù±¾n¡Ý30£¬ËùÓÐÖظ´Ñù±¾×ÔÁ¦ÆÊÎö
ÆäËûÖÖÀàµÄÑùÆ·ÔÚÍøÂç֮ǰÇëÁªÏµ¹«Ë¾ÏúÊÛ¹¤³Ìʦ
? ¼ì²âƽ̨
Qtrap 6500+, Sciex
? ͨÀýÏîÄ¿ÖÜÆÚ
ʵÑé¼ì²â£º45¸ö×ÔÈ»ÈÕ£¨´ÓÊÕµ½¿Í»§Ô¤¸¶¿î²¢ÊÕµ½ÑùÆ·Ö®ÈÕÆð£©
Êý¾ÝÆÊÎö£º5¸ö×ÔÈ»ÈÕ
-
¶¯Ö²ÎïÐÄÀí¹¦Ð§Ñо¿
-
ÁÙ´²¼²²¡²¡Àí»úÖƵÄÑо¿£¬ÔçÆÚÕï¶Ï
-
΢ÉúÎïÉú³¤¹¦Ð§Ñо¿
Ñо¿¹¤¾ß£º СÊó
ÆÚ¿¯£º Journal of Neuroinflammation
Ó°ÏìÒò×Ó£º 9.587
ʱ¼ä£º 2021Äê
ϵͳÐÔºì°ßÀÇ´¯(Systemic Lupus Erythematosus, SLE)ÊÇÒ»ÖÖÀÛ¼°È«Éí¶à¸öÆ÷¹ÙµÄ×ÔÉíÃâÒßÐÔ¼²²¡¡£ÁÙ´²ÉÏ£¬12-95%µÄSLE»¼Õß·ºÆð¾«ÉñºÍÉñ¾ÏµÍ³Ö¢×´£¬Ò²³ÆΪÉñ¾¾«ÉñÐÔϵͳÐÔºì°ßÀÇ´¯(NPSLE)£¬ÑÏÖØÓ°ÏìÉúÑÄÖÊÁ¿£¬ÔöÌí¼²²¡Ïà¹ØéæÃüÂÊ¡£ÔÚÃÀ¹ú·çʪ²¡Ñ§»á(ACR)½ç˵µÄ19ÖÖNPSLE×ÛºÏÕ÷ÖУ¬ÈÏÖª¹¦Ð§ÕÏ°±»ÒÔΪÊÇSLE×îÍ´¿àµÄÖ¢×´Ö®Ò»¡£ËüµÄÉú³¤ÊÇ×ÔÁ¦ÇÒÒþ²ØµÄ£¬Í¨³£¶Ô±ê×¼µÄÃâÒßÒÖÖÆûÓз´Ó¦¡£Ô½À´Ô½¶àµÄÖ¤¾ÝÅú×¢£¬ÖØ´óºÍÏ໥¹ØÁªµÄ»úÖÆÔö½øÁËSLEÈÏÖªÕÏ°µÄÉú³¤£¬µ«ÏêϸµÄ×÷ÓûúÖÆÈÔ²»ÇåÎú¡£
? Ñо¿Ð§¹û
±¾Ñо¿Ì½ÌÖÁËС½ºÖÊϸ°ûÔÚNPSLEСÊóÈÏÖª¹¦Ð§ÕÏ°ÖеÄ×÷Óã¬ÆÊÎöºÍ½ÏÁ¿ÁËÉñ¾¾«ÉñÐÔϵͳÐÔºì°ßÀÇ´¯Ä£×ÓСÊóºÍ±ÈÕÕ×éСÊóº£ÂíÇø×éÖ¯ÖеĴúлÎƾ֤ÕâЩת±ä£¬·¢Ã÷Á˱ûͪËἤøÑÇÐÍM2(PKM2)¿ÉÄÜÊÇÓÕ·¢NPSLEµÄÒªº¦·Ö×Ó£¬½ø¶ø̽ÌÖÁËϵͳÐÔºì°ßÀÇ´¯(SLE)½éµ¼µÄÈÏÖªºÍÄÔËðÉ˵ķ¢²¡»úÖÆ¡£
? Ñо¿Ë¼Ð÷
? Ч¹ûչʾ
Óë±ÈÕÕ×éÏà±È£¬MRL/lprÀÇ´¯Ð¡Êóº£ÂíÌǽͽâÔöÌí(ͼ1)£¬ÆÏÌÑÌÇÏûºÄºÍÈéËáÌìÉúÔöÌí£¬º£ÂíÇøС½ºÖÊϸ°ûPKM2¼¤»î(ͼ2)¡£PKM2ͨ¹ý¦Â-cateninÐźÅͨ·Ôö½øС½ºÖÊϸ°û¼¤»îºÍÌ«¹ý¼¤»îС½ºÖÊϸ°ûÍÌÊÉ(ͼ3)¡£ÒÖÖÆС½ºÖÊϸ°ûPKM2¿ÉÒÔ¼õÇáMRL/lprСÊóµÄÈÏÖªÕÏ°ºÍÄÔËðÉË£¬²¢Í¨¹ý×è¶Ï¦Â-cateninÐźÅͨ·À´ïÔÌС½ºÖÊϸ°ûµÄ¼¤»îºÍÉñ¾ÔªÍ»´¥µÄɥʧ(ͼ4)¡£
ͼ1. ÖÐÐÄ̼´úл×éÆÊÎöÏÔʾMRL/LPRСÊóº£ÂíÌǽͽâ´úл²úÆ·ÔöÌí
ͼ2. ÌǽͽâøPKM2ÔÚNPSLEСÊóÌåÄÚ±í´ïÉϵ÷
ͼ3. NPSLE¼¤»îС½ºÖÊϸ°û£¬ÓÕµ¼Éñ¾ÔªÍÌÊÉ
ͼ4. ÒÖÖÆС½ºÖÊϸ°ûPKM2¿É¼õÇáMRL/LPRСÊóµÄÄÔËðÉ˺ÍÈÏÖªÕÏ°
? ÎÄÏ×·ÖÏí
Li Lu, Hailin Wang, Xuan Liu et al., Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the ¦Â-catenin signaling pathway. J Neuroinflammation, 18, 229, 2021. https://doi.org/10.1186/s12974-021-02279-9.